X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (60746) 60746
Newspaper Article (2412) 2412
Newsletter (1212) 1212
Book Chapter (394) 394
Magazine Article (246) 246
Book / eBook (47) 47
Transcript (39) 39
Dissertation (36) 36
Trade Publication Article (26) 26
Web Resource (24) 24
Reference (16) 16
Book Review (15) 15
Conference Proceeding (14) 14
Government Document (8) 8
Publication (8) 8
Paper (5) 5
Report (5) 5
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49388) 49388
male (29936) 29936
female (29717) 29717
adult (23584) 23584
middle aged (22328) 22328
hepatitis (19523) 19523
gastroenterology & hepatology (13588) 13588
aged (11757) 11757
risk factors (10458) 10458
hepatitis c (10314) 10314
hepatitis b (9318) 9318
liver (9048) 9048
health aspects (8275) 8275
hepatitis b - complications (7987) 7987
hepatitis c virus (7799) 7799
adolescent (7081) 7081
infection (6882) 6882
hepatitis c - complications (6762) 6762
infections (6724) 6724
infectious diseases (6614) 6614
cirrhosis (6510) 6510
prevalence (6465) 6465
antiviral agents - therapeutic use (6330) 6330
liver diseases (6102) 6102
hepatitis b virus (5920) 5920
treatment outcome (5637) 5637
liver cirrhosis (5579) 5579
care and treatment (5499) 5499
retrospective studies (5353) 5353
research (5050) 5050
patients (4919) 4919
analysis (4831) 4831
transplantation (4830) 4830
disease (4807) 4807
immunology (4758) 4758
hepatitis c, chronic - complications (4733) 4733
hepatocellular carcinoma (4604) 4604
interferon (4495) 4495
mortality (4467) 4467
young adult (4364) 4364
surgery (4334) 4334
hiv (4198) 4198
liver cancer (4184) 4184
child (4147) 4147
diagnosis (4131) 4131
prognosis (4062) 4062
hiv infections - complications (4052) 4052
biopsy (3927) 3927
virology (3898) 3898
viruses (3889) 3889
therapy (3886) 3886
liver - pathology (3855) 3855
fibrosis (3851) 3851
hepatitis b, chronic - complications (3838) 3838
hepatocellular-carcinoma (3775) 3775
medicine, general & internal (3749) 3749
liver transplantation (3724) 3724
risk (3704) 3704
pregnancy (3684) 3684
epidemiology (3597) 3597
oncology (3463) 3463
virus-infection (3453) 3453
medicine & public health (3425) 3425
virus diseases (3421) 3421
animals (3358) 3358
medicine (3258) 3258
hepatitis c, chronic - drug therapy (3245) 3245
complications and side effects (3220) 3220
medical research (3190) 3190
genotype (3186) 3186
hepatology (3125) 3125
prospective studies (3022) 3022
follow-up studies (2938) 2938
cancer (2909) 2909
gastroenterology and hepatology (2905) 2905
hepatitis c - epidemiology (2903) 2903
liver cirrhosis - complications (2877) 2877
time factors (2868) 2868
antiviral agents (2859) 2859
research article (2842) 2842
drug therapy (2834) 2834
hepatitis b - epidemiology (2786) 2786
aged, 80 and over (2753) 2753
hepacivirus - genetics (2669) 2669
studies (2669) 2669
human immunodeficiency virus--hiv (2640) 2640
development and progression (2585) 2585
liver neoplasms - etiology (2584) 2584
digestive system diseases (2530) 2530
risk-factors (2508) 2508
medicine, experimental (2506) 2506
liver cirrhosis - etiology (2448) 2448
gastroenterology (2438) 2438
child, preschool (2424) 2424
hcv (2419) 2419
cohort studies (2400) 2400
drug therapy, combination (2400) 2400
prevention (2377) 2377
carcinoma, hepatocellular - etiology (2369) 2369
disease progression (2349) 2349
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (14) 14
Online Resources - Online (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (60895) 60895
French (958) 958
German (664) 664
Chinese (647) 647
Russian (561) 561
Spanish (529) 529
Japanese (431) 431
Italian (269) 269
Polish (218) 218
Korean (122) 122
Portuguese (89) 89
Hungarian (62) 62
Czech (50) 50
Dutch (49) 49
Turkish (43) 43
Serbian (40) 40
Croatian (36) 36
Danish (36) 36
Romanian (36) 36
Swedish (24) 24
Ukrainian (16) 16
Arabic (15) 15
Norwegian (15) 15
Hebrew (12) 12
Slovak (12) 12
Bulgarian (10) 10
Urdu (10) 10
Persian (5) 5
Finnish (4) 4
Hindi (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 2017, Volume 123, Issue 11, pp. 1904 - 1911
Immune checkpoint inhibitors, including those targeting the programmed cell death 1/programmed cell death ligand 1 and cytotoxic T lymphocyte antigen 4... 
pembrolizumab | autoimmune | nivolumab | elderly | ipilimumab | pediatrics | pregnancy | transplant | organ dysfunction | ALLOGRAFT-REJECTION | PERFORMANCE STATUS | PD-1 BLOCKADE | OPEN-LABEL | CELL LUNG-CANCER | IPILIMUMAB THERAPY | ONCOLOGY | ADVANCED MELANOMA | BRAIN METASTASES | AUTOIMMUNE-DISEASE | T-CELLS | Lung Neoplasms - drug therapy | Melanoma - complications | Age Factors | Humans | Immunosuppressive Agents - therapeutic use | Ipilimumab | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Hepatitis C, Chronic - complications | Transplant Recipients | Neoplasms - complications | Brain Neoplasms - secondary | Squamous Cell Carcinoma of Head and Neck | Pregnancy Complications, Neoplastic - drug therapy | Female | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - complications | Graft Rejection - prevention & control | Autoimmune Diseases - complications | Head and Neck Neoplasms - drug therapy | Brain Neoplasms - drug therapy | Lung Neoplasms - complications | Neoplasms - drug therapy | Pregnancy | Carcinoma, Non-Small-Cell Lung - complications | B7-H1 Antigen - antagonists & inhibitors | Carcinoma, Squamous Cell - drug therapy | Hepatitis B, Chronic - complications | Carcinoma, Squamous Cell - complications | Melanoma - drug therapy | Nivolumab | HIV Infections - complications | Head and Neck Neoplasms - complications | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Renal Cell - complications | Immunocompromised Host | CTLA-4 Antigen - antagonists & inhibitors | Kidney Neoplasms - drug therapy | Virus diseases | Care and treatment | Dosage and administration | Research | Cell death | Immunosuppressive agents | Medical research | Brain | Populations | Toxicity | Decision making | Mortality | Disorders | Clinical trials | Cytotoxicity | Lymphocytes T | Metastasis | Patients | Regulatory approval | Metastases | Inhibitors | Immune checkpoint | Aggregates | Lymphocytes | Safety | Autoimmune diseases | Cancer | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
PLOS ONE, ISSN 1932-6203, 07/2016, Volume 11, Issue 7, p. e0158090
Background Hepatitis B (HBV), hepatitis C (HCV) and other sexually transmitted infections (STIs... 
MORTALITY | B-VIRUS | WOMEN | RISK-FACTORS | HEPATITIS-C VIRUS | SEMEN | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | COHORT | HUMAN-PAPILLOMAVIRUS INFECTION | EPIDEMIOLOGY | Virus Diseases - epidemiology | Prevalence | Cytomegalovirus Infections - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Hepatitis B - epidemiology | Male | Sexually Transmitted Diseases - epidemiology | Cytomegalovirus Infections - complications | Virus Diseases - complications | Sexually Transmitted Diseases - complications | Hepatitis B - complications | Bacterial Infections - complications | Homosexuality, Male | Hepatitis C - epidemiology | Adult | Hepatitis C - complications | Surveys and Questionnaires | Gonorrhea - epidemiology | Papillomavirus Infections - complications | Sexual Behavior | Papillomavirus Infections - epidemiology | Chlamydia Infections - complications | Syphilis - epidemiology | Chlamydia Infections - epidemiology | Coinfection - epidemiology | Disease Progression | Bacterial Infections - epidemiology | HIV Infections - complications | Ontario - epidemiology | Herpes Simplex - complications | Gonorrhea - complications | Sexual Partners | Syphilis - complications | Herpes Simplex - epidemiology | Sexually transmitted diseases | Demographic aspects | Sexual behavior | Research | Gay men | Risk factors | HIV seropositivity | Diseases | Drug abuse | Sexually transmitted diseases--STD | Laboratories | Sex | Herpes simplex | Viruses | Infections | Serology | Hepatitis | Human papillomavirus | Acquired immune deficiency syndrome--AIDS | Chlamydia | Syphilis | Health care networks | Human immunodeficiency virus--HIV | Hepatitis B virus | Public health | Urine | Cytomegalovirus | Bacterial infections | Health risks | Gonorrhea | Medicine | Disease transmission | Womens health | Herpes viruses | Men | Hepatitis C virus | Hepatitis C | Health risk assessment | Native North Americans | Sexual partners | Hepatitis B | STD | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 09/2019, Volume 82, Issue 1, pp. 71 - 80
BACKGROUND:Hepatitis B virus (HBV) infection is a leading cause of end-stage liver disease (ESLD... 
INFECTIOUS DISEASES | hepatitis B | CHRONIC HEPATITIS-B | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | NATURAL-HISTORY | end-stage liver disease | HIV-INFECTION | HIV | SIMPLE NONINVASIVE INDEX | SIGNIFICANT FIBROSIS | CIRRHOSIS | CLINICAL-IMPLICATIONS | coinfection | hepatocellular carcinoma | NORTH-AMERICA | Carcinoma, Hepatocellular - epidemiology | Gastrointestinal Hemorrhage | Liver Cirrhosis - complications | United States | HIV Infections - epidemiology | Humans | Liver | Middle Aged | Risk Factors | Liver Neoplasms - complications | Hepatitis B - epidemiology | Male | CD4 Lymphocyte Count | Hepatitis B - complications | Liver Cirrhosis - epidemiology | Canada | Liver Neoplasms - epidemiology | Esophageal and Gastric Varices | Carcinoma, Hepatocellular - complications | HIV Infections - complications | Adult | End Stage Liver Disease - complications | Female | Retrospective Studies | Viruses | Hepatocellular carcinoma | Hemorrhage | Alcohol use | Confidence intervals | Hepatitis | Acquired immune deficiency syndrome--AIDS | Cooperation | Encephalopathy | Human immunodeficiency virus--HIV | Race | Hepatitis B virus | Peritonitis | Liver diseases | Statistical analysis | Complications | Diabetes mellitus | Health risks | CD4 antigen | Collaboration | Fibrosis | Alcoholic beverages | Determinants | Diabetes | Ascites | Hepatic encephalopathy | Hepatitis B | Index Medicus | AIDS/HIV
Journal Article
Journal Article
Hepatology (Baltimore, Md.), ISSN 1527-3350, 2016, Volume 65, Issue 2, pp. 414 - 425
... score CHC chronic hepatitis C CIs confidence intervals gGT gamma‐glutamyl transpeptidase HBeAg hepatitis B e antigen HbsAg hepatitis B surface antigen HBV hepatitis... 
SUSTAINED VIROLOGICAL RESPONSE | ALL-CAUSE MORTALITY | B-VIRUS | INTERFERON | THERAPY | RNA | ENTECAVIR TREATMENT | INFECTION | TIME | GASTROENTEROLOGY & HEPATOLOGY | FAMCICLOVIR TREATMENT | Multivariate Analysis | Liver - pathology | Follow-Up Studies | Humans | Middle Aged | Liver Cirrhosis - mortality | Male | Reference Values | Liver Neoplasms - mortality | Cause of Death | Dose-Response Relationship, Drug | Liver Neoplasms - etiology | Young Adult | Hepatitis D - drug therapy | Liver - drug effects | Time Factors | Adult | Female | Hepatitis Delta Virus - drug effects | Liver Neoplasms - pathology | Retrospective Studies | Drug Therapy, Combination | Severity of Illness Index | Liver Cirrhosis - etiology | Drug Administration Schedule | Risk Assessment | Antiviral Agents - therapeutic use | Hepatitis Delta Virus - isolation & purification | Interferon-alpha - therapeutic use | Kaplan-Meier Estimate | Logistic Models | Treatment Outcome | Chi-Square Distribution | Hepatitis D - diagnosis | Disease Progression | Analysis of Variance | Hepatitis D - mortality | Antiviral Agents - adverse effects | Adolescent | Survival Analysis | Liver Cirrhosis - pathology | Interferon-alpha - adverse effects | Germany | Cohort Studies | Hepatitis | Liver | Interferon | Syngeneic grafts | Hepatocellular carcinoma | Ribonucleic acid--RNA | Patients | Cirrhosis | α-Interferon | Allografts | Encephalopathy | Ascites | Hepatic encephalopathy | Liver transplantation
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 2013, Volume 19, Issue 43, pp. 7630 - 7638
Pregnancy is a special clinical state with several normal physiological changes that influence body organs including the liver. Liver disease can cause... 
Pregnancy | Cirrhosis | Viral hepatitis | Liver | Gallstones | Autoimmune | Adenoma | VIRAL LOAD | INFANT TRANSMISSION | PERINATAL TRANSMISSION | RISK-FACTORS | BUDD-CHIARI-SYNDROME | AUTOIMMUNE HEPATITIS | B-VIRUS | HEPATITIS-C VIRUS | PRIMARY BILIARY-CIRRHOSIS | TO-CHILD TRANSMISSION | GASTROENTEROLOGY & HEPATOLOGY | Liver - virology | Pregnancy Complications, Neoplastic - diagnosis | Predictive Value of Tests | Liver - pathology | Prognosis | Humans | Pregnancy Complications, Neoplastic - metabolism | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Pregnancy Complications, Infectious - metabolism | Pregnancy Complications, Cardiovascular - metabolism | Pregnancy Complications - mortality | Female | Pregnancy Complications - metabolism | Pregnancy Complications, Infectious - mortality | Pregnancy Complications, Cardiovascular - diagnosis | Pregnancy Complications, Cardiovascular - mortality | Pregnancy Complications, Infectious - diagnosis | Pregnancy Complications, Cardiovascular - therapy | Hepatitis, Viral, Human - therapy | Liver - metabolism | Pregnancy Complications, Neoplastic - mortality | Liver Diseases - therapy | Pregnancy Complications - diagnosis | Liver Neoplasms - diagnosis | Liver Neoplasms - metabolism | Pregnancy Complications, Neoplastic - therapy | Hepatitis, Viral, Human - metabolism | Liver Diseases - mortality | Liver Diseases - diagnosis | Hepatitis, Viral, Human - mortality | Liver Diseases - metabolism | Hepatitis, Viral, Human - diagnosis | Pregnancy Complications, Infectious - therapy | Pregnancy Complications - therapy | Minireviews
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2017, Volume 23, Issue 5, pp. 776 - 791
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 52, Issue 2, pp. 252 - 257
... associated with liver cirrhosis resulting from chronic liver diseases. Among the environmental risk factors, the prevalence of chronic hepatitis B (HBV) and C (HCV... 
Gastroenterology and Hepatology | Cirrhosis | Hepatitis | Porphyrias | Hemochromatosis | Tyrosinemia type I | Glycogen storage disease | Non-alcoholic steatohepatitis | PRIMARY HEPATOCELLULAR-CARCINOMA | PORPHYRIA-CUTANEA-TARDA | SUSCEPTIBILITY | FOLLOW-UP | HEREDITARY HEMOCHROMATOSIS | DISEASE TYPE-I | HEPATOCARCINOGENESIS | PRIMARY LIVER-CANCER | Tyrosinemia type 1 | HEPATITIS-B | GASTROENTEROLOGY & HEPATOLOGY | VIRAL-HEPATITIS | Humans | Hypothyroidism - complications | Fatty Liver - complications | Male | Porphyrias, Hepatic - genetics | Glycogen Storage Disease Type I - complications | Liver Neoplasms - etiology | Hemochromatosis - complications | Carcinoma, Hepatocellular - genetics | Female | Carcinoma, Hepatocellular - etiology | Diabetes Complications - genetics | Hepatitis, Autoimmune - genetics | Hemochromatosis - genetics | Fatty Liver - genetics | alpha 1-Antitrypsin Deficiency - genetics | Genetic Predisposition to Disease | Liver Neoplasms - genetics | Risk Factors | Tyrosinemias - genetics | Diabetes Complications - etiology | Tyrosinemias - complications | Hepatitis, Autoimmune - complications | Glycogen Storage Disease Type I - genetics | alpha 1-Antitrypsin Deficiency - complications | Models, Genetic | Porphyrias, Hepatic - complications | Type 2 diabetes | Liver cancer | Histocompatibility antigens | Glycogen | Glutathione transferase | HLA histocompatibility antigens | Genetic research | Genetics | Hepatitis C
Journal Article